Citations

1. Schachter SC (2003). Epilepsy: Etiology and manifestations. In RW Evans, ed., Saunders Manual of Neurologic Practice, part VII, pp. 244–265. Philadelphia: Curtis Center.

2. Christensen J, et al. (2007). Epilepsy and the risk of suicide: A population-based case-control study. Lancet Neurology. Published online July 3, 2007 (doi:10.1016/S1474-4422(07)70175-8).

3. Bazil CW, et al. (2005). Epilepsy. In LP Rowland, ed., Merritt's Neurology, 11th ed., pp. 990–1014. Philadelphia: Lippincott Williams and Wilkins.

4. Blume WT (2003). Diagnosis and management of epilepsy. Canadian Medical Association Journal, 168(4): 441–448.

5. French JA, et al. (2004). Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 62(8): 1252–1260.

6. Wiebe S, et al. (2001). A randomized, controlled trial of surgery for temporal-lobe epilepsy. New England Journal of Medicine, 345(5): 311–318.

Other Works Consulted

• Diaz-Arrastia R, et al. (2002). Evolving treatment strategies for epilepsy. JAMA, 287(22): 2917–2920.

• Hanhan UA, et al. (2001). Status epilepticus. Pediatric Clinics of North America, 48(3): 683–694.

• Tudur Smith C, et al. (2007). Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database of Systematic Reviews (1).